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Objoctiws. We examiaed tbe possible e&t of neuropeptide Y in 
modulating central sympathetic activity after myocardial infarc- 
tioninrats. 
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Neuropeptide Y is colocalixed with norepinephrine in the 
braiu and has been identihed in abundance in the central as 
weU as the peripheral nervous system of many species (l-7). 
Neumpeptide Y inhibits the release of norepinephrine at the 
presynaptic level (g.9) and can bc considered to act as a 
nemomodulator (19-13). In the brain, the highest densities ot 
ncuropeptide Y fibers and perikarya are found in the hypotha- 
lamic pamventricular nucleus (14,lS). Stimulation of the para- 
ventricular nucleus increases sympathetic outflow (16) which 
precipitates an incmase in peripheral sympathetic nerve activ- 
ity, as gauged by an elevation of plasma catecholamines in the 
systemic circulation (17). We sought to investigate how neu- 
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tbe paraventricular nucleus was also carried out in the experi- 
meutal and sham groups. 
Rest&s. Tbe concentration of norepinephrine measured in the 
samples was decreased by 50% with neompeptide Y in 2. and 
4-week old rats after infarction, but by only Xl% (p C 0.05) in 
S-week old tats after infarction. Tbe dimiaisked inhibitory e4fect.s 
of aeuropeptide Y oa nompinepbrine release was associated witb 
increased sympatketic activity, as m&ted by plasma norepiaepb- 
rine; 8-week old rats after infarction bad almost a 100% (p < 0.05) 
increase ia tkeir plasma norepiwpbrine level compared with tbe 
sham group. AtiWdhgmphy revealed a signiicaut dewease ia 
density of wwopepMe Y mceptors in tbe pamventricular nu- 
clem in t?-wek old rats after inf&tion (p < 0.05). 
Coaai~~iaas. The data presented in tbis report suggest tbat tbe 
redncthn of tbe i&ibitoty activation of ueuropeptide Y on 
sympathetic release may contribute to elevated norepinepiuine 
levels after myocanM infarction. 
(J Am Cd Gudiol1996;27:1796-SO3) 
ropeptide Y modulates sympathetic outflow in ditIerent pathc- 
physiologic conditions. 
Myocardial infarction in both patients and experimental 
animal models has been shown to be associated with an 
increased sympathetic drive (18). However, the reason for 
hetghtened sympathetic activity and concurrent pathophysio- 
logic findings after myocardial infarction has yet to be satisfac- 
torily explained. The main objective of this study was to 
examine the hypothesis that neuropeptide Y is involved in 
ischemic heart disease through altered sympathetic activity in 
the pamventricular nucleus of the hypothalamus, which is one 
of the prominent catecholamine-rich cardiovascular centers in 
the brain. Focusing on the importance of the paraventticular 
nucleus in the control of sympathetic activity and nemopeptide 
Y as a neuromodulator, we tried to determine the. relation 
between neuropcptide Y as a neuromodulator and myocardiai 
infarction. 
Myocardial infarct&n was prorhued in 
male S;rque&wley rats weighing 175 to 225 g by occlusion 
of the Iefi coronmy artery (19-21). After the animals were 
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anesthetized with ether, the skin was incised along the left 
sternal border, the fourth rib was cut proximal to the sternum 
and retractors were inserted. The pericardial sac was perfo- 
rated and the heart was exteriorized through the intercostal 
space. The left coronary artery was ligated -2 mm from its 
origin with 6-O silk suture, and the heart was repositioned in 
the chest. Throughout the operation, the rats were maintained 
on a positive-pressure ventilation system delivering a mixture 
of 95% oxygen and 5% carbon dioxide, together with ether. 
Closure of the wound was accomplished by a pursestring 
suture. Sham-operated animals were treated similarly, except 
that the suture around the coronary artery was not tied. 
Animals were housed on a dark-light cycle of 12/12 h and 
allowed to recover in a temperature-controlled environment 
with free access to food and water. The animals were main- 
tained for 2, 4 and 8 weeks before the experimental assess- 
ments. The mortality rate of alf animals operated on was 35% 
within 72 h after surgery. Each group had six animals 2,4 and 
8 weeks aftet infarction. 
To examine the general characteristics of the animals and 
the weight of the seat tissue, the right and left ventricles of tbe 
heart was taken. The weight of the left ventricle did not include 
the scar tissue. Fit the lungs were dissected and their wet 
weight measured. Before dry weight was measured, the rats’ 
lungs were kept inside an oven for 48 h at 6C“C. 
MlawliatgsiF, in vitm. Microdialysis probes (CMA/5OO+m 
outer diameter, 1 mm exposed dialysis membrane, Carnegie 
Medicine/Bio Analytical Systems) were perfused with micro- 
dialysis pertirsate (in mmohlitet: 147 sodium chloride, 4 potas- 
sium chloride, 1.2 cakium chloride, 1.1 magnesium chloride, 
pH 6) at a flow rate of 2.2 pl/min and mounted in Eppendorf 
vials containing a known concentration of norepinephrine (100 
ng,+i) dissolved in microdialysis perfusate. Microdialysis 
probes wete calibrated before the experiments (2223). Refa- 
tive recovery was defined as concentration of catecholamines 
in perfirsate as a percentage of the concentration of the outer 
medium. After calibration, the probes were set to zero on the 
Kopf stereotic frame /David Kopf fnstmments). 
Mkrodialysis in viva. Miiialywis was carried out 2 4 
and 8 weeks after coronary artery ligation (6 animals in both 
the experimental and control groups 24 and 8 weeks after 
infarction). The animals were anesthetized with 4.0 mgilO0 g 
ketamine:0.4,mg/lOO g aylazine intraperitonealfy ano placed in 
a David Kopf steteotactic apparatus with the incisor bar 
elevated to 5 mm above the interaural line. Body temperature 
was maintained at 3PC by a Harvard homeothermic control 
pad (Harvard Apparatus, Inc.). Craniotomy was perfomred 
and the probe was steteotacticaffy inserted into the paraven- 
trkular nucfeus. Coordiies used were +1.0/+0.5/-8.0 for 
the 2- and 4-week old animals and +i.l/+OJ/-8.3 for the 
8-weekofdanbnah,fmmtbeaerobarinmiUimeters,oftbe 
brain’s antempo6te~/~~~ttal tegbm te- 
SpedtiN 
brain at a Row rate of 2.2 r.rl/min. After the stabilization period, 
IO0 rd of the microdialysate samples was collected and imme- 
diately taken for tbe purification procedure before catechol- 
amine analysis in high performance liquid chromatography. 
The animals were then intracerebrally exposed to a freshly 
prepared solution of neuropeptide Y (concentration of 
10-s mohliter) dissolved in the microdialysis pxfitsate. After 
an.rthet stabilization period of 1 h, 100 ~1 of microdialysate 
sample was again collected for catecholamiae analysii to 
examine the effect of neuropeptide Y. 
PurMcatfnn and nempinepbrfne analysis. The puritication 
procedure was carried out by means of an alumina extraction 
protocol (Waters-Millipore, Mississauga, Ontario, Canada). 
Basically, the samples were treated with 2 mobliter Tris and 
the pH was adjusted to 8.7. Acid-washed alumina (20 mg) was 
added to the vial and allowed to mix for 20 min. The 
supematant was discarded and the alumina was washed three 
times with doubledistilled water. The alumina was dried on 
filter paper and catecholamiis were eluted from tbe alumina 
with 0.1 N acetic acid. Notepinephrine analysis was performed 
by injecting the purified samples during reverse-phase higb 
.xrformance liquid chromate with an efectrodKmrcal 
detector. High performance liquid chromatography consisted 
of Waters Resofve 5-m Cl8 dimethyloctadecylsifyl-bonded 
silica particle size in a 3.9mm X GO-mm column, a 510 pump, 
a U6K lid injector and a 460 electrochemical detector. The 
glassy carbon working electrode was set at +0.60 V versus a 
silver/silver chloride referencz electrode. The mobile phase 
consisted of Waters catecholamine eluent reagent, whii was 
regularly degas& and circulated at a flea rate of 0.9 ml/mm 
Concentrations were obtained after cbromatographii compar- 
ison with a standard containing a known concentration of 
notepinepbrine (100 ng@). The cbromatograpbic data were 
collected on a m’ mmcomgutet using Baseline 810 chromate- 
graphic workstation software. 
Four mifliliten of bfood 
ed plasma was purified 
through an ahmina extra&on protocoi t Watets-Milliij 
similat to tbe m&&&ate sampies. Norepinephrine analysb 
was performed during higb performance liquid chmmatogra- 
phy with an electrochemical detector. Concentrations were 
o&a&d as in the i&ro&aly6~ Sat+IsS after chromate- 
gtaphti amp&m to a standard known concentration of 
llDtf+~hlille. 
l%sfihndw Aftertbemiaodialysir 
sampf&eachanimafwasremovedfromtbeKopfstereotadic 
bameandintrxardialfy@iuxdwith09%sabneatroom 
temperarm, foRowed by 4% paraformaldebyde in 0.1 mob 
titer phosphate buffer (pH 7.4). Tbe rats’ heads were sepanted 
befowtbesecondcervicalvertebra.andaftetc&otomytbeir 
braimwetebloekedrnltbesteteotadic~*the 
incisorbar5mmabovetheinteraurafbnelhebrafnsegmems 
werecrpproteaedin25%smxose:Rt%ptyoerioin0.1arou 
~er@ospbateb&etfor3days.Tbeyateretbestse&ltedia 
ayostatataamstanttemperatmeof-lPC.witbatMdmem 
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Pigae1.K~ephet~ofacrossrectionofthebrain, 
demonstratingplammentofamicmdi@&proheinanareaoftheparaven- 
tdeular imdeus (PVN) in coronary artely-hgated tats. cinresPondiig secttom 
fmm sham-operated amtrol animals showed sin&r tirdiags. The amm 
iudkates the tip of the microdialysis prehe in the paravenuieutar nucleus 
region. A, Low magnitication. B, Magnification of endosed box simt: in A. 
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of 40 pm. Sections were mounted and stained with thionin on adjacent sections in the absence and presence of 1 FmoV 
Ni stain, and probe insertion site was histologically con- liter porcine neuropeptide Y. 
firmed (Fig. IA, B). The sections were then washed in chiUed Tris hydrochloride 
To confirm the extent of collagen deposition, histologic buffer four times for 4 mitt each, followed by a dip in chilled, 
secbons of the hearts of 2-, 4- and g-week old animals were double-distilled water. The sections were quickly air dried and 
taken and stained with h4artiu.s scarlet blue trichrome stain, then tightly juxtaposed against hydrogen-3 Hyperfilm (Amer- 
which hmts the collagen fibers a blue color. sham) sealed within Picker International cassettes. The boxes 
AuIndlogrttpltyfor~YRceQtors Theauto- were stored at 4°C for 4 days ‘before developing Measure- 
radiogmphii technique performed in this study has been nwnw of receptor concentration were carried out using the 
modified from the work of M&.lel et al. (24). There were six armputer image analysii system (Jandel Scientific). Altemat- 
animals in each of the experimental and sham groups 8 weeks ing sections were stained with thiiin to facilitate anatomic 
after infatct+m. The animals 19 both groups were quickly identification. 
decapitated and StereotactiAly blocked in a David Kopf In the autoradiographii experiments, the rat brains were 
appmtm The lhckd brains were immediately froxen in dry sectioned and thaw mounted on slides without undergoing 
iceandcutto~~Wknessonacryostatatacomtant prior cryoprotection to avoid any interference of salt ions with 
of-13”c.TheseclimswereIhawmomlIedon 
rw 
our radioactive isotope, iodine-l25 neuropeptide Y. Fresh sets 
rdidesandstoredat-~forfutureuse. of rat$ other than those used for the micmdiii experi- 
During autoradiiy the sections were thawed at room 
temperaiure aud then pre&ubaIed in 50 mmobliter Tris 
ments, were taken for the experimental group and the sham 
group. This was done primarily to avoid desensitization of the 
ltydmdtoride, pH 7.4, at room temperature for 45 mm. neuropeptide Y receptors in the paraventricular mrcleus area 
During incubation the brain metions were exposed to 0.2 nmol of the brain during the microdii experiments in which the 
iudine-12.5 Bolton Hunter m 
(7.4 X 10’ MBq/mmo#) for 120 mm. ;t hail 
concenIraIifn~ of nemopeptide Y was JO-* mol/liter. 
sItstistical All data are presented as mean 
v&e 2 SEM. diferences henveen mea0 wlttes of 
eRpcrimenIBl BBd sham-operated amrol animals were ana- 
lyzed using mwvay analysis of variance with T&y’s muhiple 
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Table 1. General Characteristics of Experimental Rats 2.4 and 8 Weeks After Induction of Myccardial infarction 
- Week 2 Week 4 Week8 
P%Xll&lS Sham Ligated Sham Ligated skam w 
LVen~wt(.g) 0.71 + 0.06 0.85 5 0.w 0.84 + 0.05 O.% 2 0.04’ 09 2 0.w 1.26 2 0.07’ 
R vent. wi (9) 0.20 2 0.02 0.212 0.04 0.23 t 0.03 0.33 2 0.04 n.24 ?: 0.01 0.34 E 0.05' 
L vent. WI (lo-‘)body WI 217 2 0.21 2.66~0.25 2.02 + 0.18 2.46 2 0.w 2412 or) 2.67 2 026' 
*w(g) ND 0.14 IO.02 ND 0.14 2 0.01 ND 0.26 L 0.03 
Lung Wet wl cd 128 2 0.18 121 f 0.16 33 2 0.12 1.66 IO.?1 1.58 = 0.17 I&l t 0.14' 
Luag@~@) 0.29 t 0.03 028 t 0.07 037 z 0.07 036 lr 0.08 039 f 0.04 0.42 2 0.03 
Lungwetwt/lmgdtywl 436 f. 033 4.36 f 0.43 4.10 ?r 031 4272029 3.93 + 0.23 438 i_ 0.21' 
*p < 0.05. Data are expressed s mean 5 SEM of SK experiments in each group. Leh venttkular (L wat.) ueighl (UT) indicated for experimntal animak doer 
m inelude xar tiwae. ND = not deteuabie; R vent. = right ventricular. 
comparison testing. Statistical significance for all the tests was 
set at p < 0.05. 
RlSUltS 
General&aracteristicsofes@me@aiar&n&. Table1 
summarizes the general dmraeteristies of the experimental 
animals24andSweeksafterinfaretionAsstudyoftbeleft 
ventride revealed sigaiit dilferences between experimental 
and &am-operated groups of animals. A study of the left 
ventride 8 weeks after infarction revealed sign&cant differ- 
ems in weight between the experimental and sham groups. 
Evidence of cardiac hypertrophy after the initial mpolnlial 
inkction was observed by the increa.d mass of the remaining 
via& left as well as the right veotriadar mytmdim in 
&week old experimental animals. Furthermo~, the ieft ven- 
triadar weight/body weight ratio was s@ScantI&gber at the 
4- and &week stages in tbe cqerimeotal animals. However, no 
dilleremx in the scar weights of the left ventrbdar free waU 
was seen among the 2-, 4- or g-week old expximentai animals. 
Congestion of lane was evident by the &eased wet and 
wet/dry lung weight ratio in the g-week old experimental rats 
(Fig. 3), 4 weeks showed an increase of more than fourfold 
(p < 0.02) (Fig. 3) and 8 weeks showed an increase of more 
than ninefold (p < 0.001) (Fig. 3), when compared with their 
respective sham-operated aaimak 
Histologic sections of the heart of g-week old experimental 
animals showed hypertmphy and extensive eoUagen tissue 
deposition (Fii. 2A, B), which reUected an increase iti tread 
from2to4to8weeksafterinfarctbx . . fWnnMy& in v+fro. Relative recovery rates of + mi- 
emddysk probes were performed every day before the exper- 
imentstodetermine.tbepnWsabilitytorecovercatedtol- 
aminefromthebrain.Therdativenxovetyrateofthepmbes 
rangedfrom1O%to15%.Probeswerep&sedwithneu- 
ropeptideYto~tbepcxsibkeffec8ofthedrugonthe 
at&y of the probe to recover noqine#u&. However. no 
dSerenceswerefoundinthenxoveryofnotepinephrineintae 
dialysatebeforeandaftertbeperf&mtimeof1h. 
piraSign&antdilTerencesinbasebe 
kfrvmtbeparavenniatlannlpelerawere 
expe&tentalrats(B)8weeksafterligatiodofthe~ky. 
IIKm?eintbesizeoft6ebeartisdearlydemorstratedmtbeseaion 
ofthetmirtfromtbeexfxkwdanitnaLTbermpointftFgtothe 
bheporlionshowsuw~ofdepcrji~ofwuagenfiberintbe 
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Ftgnre 3. Baseline norepinephrine levels in the pamventricular nu- 
cleus of sham control and experimental animal 2,4 and 8 weeks after 
coronary artery t&ion. Released concentration (Cont.) values of 
norepinephrine tp&d of sample) are presented as the mean value + 
SEM of six animah in each gronp. Baseline samples were collected ? h 
atier implantation of the microdiatysis probe *p < O.n5, **p < &oOI, 
cumpared with the sham-operated control animals. O~XR bar5 = 
sham; dattd bars = experimental. 
After the administration of neuroneutide Y at a concentra- 
tion of lo-’ mohiiter, norepinephrine’levels of the paraven- 
trkular nucleus in all theshamoperated control groups de- 
creased by 50% to 60% when compared with the predrug 
basefine levels obtained before neuropeptide Y infusion (Fig. 
4). Red&on was 70% (Fig. 4) in 2-week old experimental 
animals and -XI% (Fig 4) in 4-week oid experimental ani- 
mals. A significant alteration was observed in g-week old 
experimental animals in which the level of norepinephrine in 
the pruaventricular nucleus changed by only 20% from the 
preneuropeptide Y level (p < 0.05) (Fig. 4). 
To veri@ whether the inhibitory effect of neuropeptide Y 
F@re 4 F&ct of neumpeptide- Y (IO-* mdniter) on the in viva 
release ofendogemn~~ r.xpine@k in UK fk3raventricular nucleus 
ofshamcootrdandexperimentalanimalsL4and8w~hafter 
ummy artery ligation. Norepinephrine release is expressed as the 
percent change from the predmg baseline levels. Opea ‘&us = sham: 
dotted bars = ,spe.imental. 
/ 
i 
Frre 5. Plasma norcpinephrine concentration (Gmc.) in sham con- 
trol and experimental animals ?,4 and 8 weeks after coronary artery 
ligation. The axxentration of norepinephrine in plasma @g/ml of 
sample) k represented as the mean value + SEM of six animals in each 
group. “p c 0.05, compared with the shamqerated control animals. 
was dose dependent, we performed experiments using other 
concentratiuns. such as lo-’ and 10.“’ mohliter. The results 
showed similar findings as those observed with the 10~* 
mol/liter concentration (Fig. 5). Thus, most of the experiments 
were performed with lo--* mot/liter concentration of neu- 
ropeptide Y. Preliminary results were also carried out to show 
that tire release of norepinephrine by neuropeptide Y was 
specific and not artifactual, as other peptides such as met- 
enkephafin failed to inhibit norepinephrine retease. 
Plasma unrx@uephrine mu@sis. Plasma levels of norepi- 
nephrine in the 2- and 4-week old experimental groups showed 
no diierences in the level of norepinephrine with their sham- 
operated group; however, the g-week old experimental group 
showed a 100% increase in the amount of norepinephrine (p < 
0.05) over the sbam group. 
Neunq@& Y receptor stndy. Figure 6B and C shows 
autoradiograms of neuropeptide Y receptors in the paraven- 
hicular nucleus area of sham and experimental rats. Nonspe- 
die binding was determined as the binding observed in the 
presence of 1.0 ~mobliter porcine neuropeptide Y (Pig. 6A). 
The densitometric measurements of these autoradiograms 
demonstrated a significant decrease in the number of neu- 
ropeptide Y receptors in the paraventricular nucleus of exper- 
imental rats as compared with the sham group, as measured by 
optical density units (Fig. 7). 
Discussion 
Congestive heart failure secondary to myocardii infarction 
of the left ventricle has been reported to occur in rats after 
surgical ligation of tire left coronq artery (21). Thii model has 
been widely accepted for studying the pa* course 
of this d&ease, and our animals with large, healed infnrcts 
slKmd§igJis~pulwwaryedema&eardiaehypcmoph~~. 
Thiswaspattieularlyevidentiu8-weekoldtatsafterinfmetiou. 
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Fsrpre 4 Autoradii of the paraventricutar nucbss of dtarn 
control and expcrimcntal animak. The arrow pint IO rhe prawn. 
hcular mrckus rcgbn of the brain. L Nmspacific tinding in rhe 
prcmce of 1.0 pmobliter porcine newopqhde Y. B. lodme-l?-c 
lKwopcpjde Y binding in the &imly”rated cornr0t rats C, Inltnc- 
125 numpqddc Y binding in tltc cnwimnral rw 8 ueeh after 
almnaly WtcIy ligation. 
Altlmgh additional lwnodpmie data are required to estab- 
lish congestive heart failure m our model, the animals did. 
indeed have a large myocardiil infarction with M early sign of 
cwgdve- heart failure. 
io oipr Our results showed that the baseline 
el in the paraventricular nudeus was ek- 
vated several times over in the experimental animats of all the 
groups. These results were similar to our earlier findings. 
where inmased relea5fz of edogenow norepineplirine from 
thepzuavetl~nudeuswarflnmdinaortic-bandel~ 
spoDtaoeous llyptemive lm (10.25). r&%qep& Y has 
beenpwMatedtortasaneommodulatorintheantralarrd 
peripheral ,qmpaMk lmvou5 systems (la,lz). f3posing the 
pameatrieuku ntieleus of sbvted animals of all three 
goapstowuropeptideyata~ntratiwofll).’mdniter 
rededinadeawedamountofnaep+Mwiotbe 
. . 
llllaodrajsatebysDsEtO~.-rmnopeptidcYdid 
nota&cttbenorepiwpbrioe~~nlesoftke~ohe5, 
tbe5echaftparenlMtlikelythensultofneuryKprideY 
aaktgatthespi&intetface.I%isisfwthersub5tantiatedby 
thefactthatneuropeptideYkakoownpesMupticinhlhiLor 
of oorepinephrioe few (9). In Ike eentId’rremous !qtem. 
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m 7. Histogram showing the number of neurtrpeptide Y receplors 
in opdcal den+y uni&. Specific binding was determined as the 
difference in binding observed on adjacent sections in the ahscnce and 
presence of 1.0 pmol/liter porcine neurqcptide Y. Data are rcpre- 
sented RS the mean value t: YEM of six animals in each group, 
compared with !hr: sham cunirol animals. *p < 0.05. 
Coacluaioas. The Pndinp UC the presmt study suggest the 
inability of neuropeptide Y IO rffeet the presynaptic inhibition 
of norcpinsphrinc release in the paraventricular nucleus, as 
evidenced by the unaltered norepinephrine levels 8 weeks after 
infarction, thus strengthening the hypothesis that the chain of 
events that initiates congestive heart failure may involve neu- 
ropeptide Y at the level of the paraventricular nucleus. In- 
creased sympathetic activity may be caused by the changes in 
action of neuropeptide Y at the level of the paraventricular 
nucleus. Further studies to define the association between 
ncuropeptide Y and congestive heart failure are clearly 
needed. 
paraventricuiar nuckus may be associated with this mcreasc in 
sympathetic drive. This augmented sympathetic drive was 
demonstrated by our plasma anaiysis of catecholamine levels. 
The S-seek old experimental group had an almost 100% 
increase in plasma norepinephrine, as cnmpared with all other 
grOW* 
Nauropeptide Y receptor study. It may be poinled oui thut 
the decreased ability of neuropeptide Y to act on the presyn- 
aptic site in the paraventricular nucleus at an advanced stage of 
congestive heart failure portrays a scrics 01 c~u.~l faclon for 
this abnormality. Keeping in mind the rok of receptors, our 
autoradiography experiment clearly shows a decrease in neu- 
ropeptide Y receptor density which may tc partrdlly ~rrpon- 
sihle for the inetTectivcness of neuropeptide Y in inhibiting 
norepincphrinc presynapticaily. Compared with the sham 
group. the numhcr of ncuropeptide Y receptors found in the 
pttravcntricu~ar nucleus was significantly less in the experimen- 
tal group of rats when analyzed statistically. This study wdS 
further supoorted by our previous experiments, which show a 
similar decrea, in neuropeptide Y receptors in the paraven- 
tricular nucleus area of the aortic-handed rats (27). 
Because ncuropeptide Y is known to coexist with norepi. 
nephrine both centrally and peripherally and there is an 
increase in sympathetic activity during congestlvc heart faiiurc, 
a downregulation of neuropeptide Y receptor kin&L5 could be 
expected in response to an increased catecholamine level and 
release. This downregulation of neuropeptide Y reccplor\ 
after myocardial infarction may aggravate the relcasc of uor- 
epinephrine and myrrartliul tlyxhmction. Studies have slut 
shown II tower level of ncuropeptide Y immunorcactivity in the 
hypertensive brain with rcspecr to normotensivt rats. where 
sympathetic activity is greater (I 1). Taken together, decreasing 
the sympathoinhibitory influe:,* of neurnpeptide Y in the 
paraventrindar nucleus, throuph whtch a decrease in neu- 
rupeptide Y receptors ic a poeibk mechanism, may reciprct 
caily increclhe qympathetr acIr tty m amgestive heart failure. 
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